# Erenumab (Genetical Recombination) S.C. Injection 70mg Pen (アイモビーグ皮下注７０ｍｇペン)

> Prescription product approved in Japan and listed on the NHI drug price list (YJ code 1190406G1029). Nifuji Pharma sources it for licensed healthcare providers, institutions, and distributors; availability, documentation, and export eligibility are confirmed on inquiry.

- **YJ code:** 1190406G1029
- **Product name (Japanese):** アイモビーグ皮下注７０ｍｇペン
- **English title:** Erenumab (Genetical Recombination) S.C. Injection 70mg Pen
- **Active ingredient:** エレヌマブ（遺伝子組換え）
- **Active ingredient (INN):** Erenumab (Genetical Recombination)
- **Strength / unit:** ７０ｍｇ１ｍＬ１キット
- **Route:** Injection (注射薬)
- **Therapeutic category:** 11 Central nervous system agents (中枢神経系用薬) › 119 Other CNS agents (その他の中枢神経系用薬)
- **Manufacturer:** Amgen (アムジェン)
- **NHI price (reference only):** JPY 38842 per ７０ｍｇ１ｍＬ１キット
- **Regulatory status:** Approved in Japan; listed on the NHI drug price list
- **Web page:** https://www.nifujipharma.com/drugs/1190406G1029
- **JSON:** https://www.nifujipharma.com/api/drugs/1190406G1029

## How to request a quotation

Submit the contact form with the product name, quantity, and destination country: https://www.nifujipharma.com/?product=Erenumab%20(Genetical%20Recombination)%20S.C.%20Injection%2070mg%20Pen%20(%E3%82%A2%E3%82%A4%E3%83%A2%E3%83%93%E3%83%BC%E3%82%B0%E7%9A%AE%E4%B8%8B%E6%B3%A8%EF%BC%97%EF%BC%90%EF%BD%8D%EF%BD%87%E3%83%9A%E3%83%B3)%20%2F%20YJ%201190406G1029#contact

Quotes are for qualified business customers only (licensed healthcare providers, medical institutions, distributors). Payment is by bank transfer in Japanese Yen. Product collection typically takes 2-4 weeks after order confirmation, followed by export procedures and shipping.